Hemoglobina glicada na APS: um indicador de qualidade no cuidado ao paciente diabético

Abstract

Diabetes mellitus is a chronic noncommunicable disease that has become increasingly prevalent worldwide, contributing significantly to morbidity and mortality, mainly due to its complications. Its development is related to several risk factors, some of which are modifiable—such as overweight, previous hyperglycemia, and alcoholism—allowing for effective prevention when addressed early. The effective management and prevention of diabetes complications require continuous monitoring of blood glucose levels. In this context, glycated hemoglobin (HbA1c) has become an essential tool for monitoring diabetic patients, as it reflects the average blood glucose levels over the previous three months, providing a more accurate representation of long-term glycemic control. This intervention project aims to highlight the importance of and implement the regular request for HbA1c, an indispensable biomarker, among diabetic patients living in the rural community of Sítio Jacaré, municipality of Alagoinha, Paraíba (Brazil). The goal is to optimize disease management, prevent complications such as neuropathy, nephropathy, retinopathy, and cardiovascular diseases, and improve the overall quality of life of affected individuals.